| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.802 | 0.004 | 0.944 | Anticonvulsant | 0.944 0.003 CID_154699623 | CID_154699623 | |
| 0.741 | 0.002 | 0.741 | Benzodiazepine agonist | 0.465 0.003 CID_154699623 | ||
| 0.548 | 0.004 | 0.548 | GABA receptor agonist | 0.418 0.004 CID_154699623 | ||
| 0.444 | 0.004 | 0.455 | DNA directed RNA polymerase inhibitor | 0.455 0.004 CID_154699623 | CID_154699623 | |
| 0.288 | 0.074 | 0.288 | 5 Hydroxytryptamine release stimulant | 0.186 0.134 CID_154699623 | ||
| 0.332 | 0.131 | 0.397 | Calcium channel L-type activator | 0.397 0.083 CID_154699623 | CID_154699623 | |
| 0.302 | 0.114 | 0.444 | GABA C receptor rho-3 antagonist | 0.444 0.044 CID_154699623 | CID_154699623 | |
| 0.218 | 0.072 | 0.218 | ErbB-1 antagonist | 0.179 0.117 CID_154699623 | ||
| 0.137 | 0.016 | 0.137 | mTOR complex 1 inhibitor | |||
| 0.184 | 0.09 | 0.207 | Psychostimulant | 0.207 0.076 CID_154699623 | CID_154699623 | |
| 0.302 | 0.21 | 0.344 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.344 0.158 CID_154699623 | CID_154699623 | |
| 0.132 | 0.047 | 0.143 | Polo-like kinase-4 inhibitor | 0.143 0.04 CID_154699623 | CID_154699623 | |
| 0.101 | 0.031 | 0.108 | Phosphodiesterase 11A inhibitor | 0.108 0.026 CID_154699623 | CID_154699623 | |
| 0.101 | 0.031 | 0.108 | Phosphodiesterase XI inhibitor | 0.108 0.026 CID_154699623 | CID_154699623 | |
| 0.158 | 0.089 | 0.187 | Death-associated protein kinase 2 inhibitor | 0.187 0.046 CID_154699623 | CID_154699623 | |
| 0.077 | 0.015 | 0.111 | Phosphodiesterase 3B inhibitor | 0.111 0.009 CID_154699623 | CID_154699623 | |
| 0.079 | 0.022 | 0.089 | MDM2 inhibitor | 0.089 0.012 CID_154699623 | CID_154699623 | |
| 0.075 | 0.032 | 0.096 | NMDA receptor glycine site agonist | 0.096 0.018 CID_154699623 | CID_154699623 | |
| 0.052 | 0.013 | 0.052 | p53 inhibitor | 0.052 0.013 CID_154699623 | ||
| 0.169 | 0.139 | 0.169 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.17 | 0.153 | 0.205 | RNA-directed DNA polymerase inhibitor | 0.205 0.092 CID_154699623 | CID_154699623 | |
| 0.075 | 0.065 | 0.114 | Glycine receptor antagonist | 0.114 0.021 CID_154699623 | CID_154699623 | |
| 0.138 | 0.129 | 0.157 | Cyclin-dependent kinase 3 inhibitor | 0.157 0.082 CID_154699623 | CID_154699623 | |
| 0.042 | 0.034 | 0.043 | Alpha 1L adrenoreceptor agonist | 0.043 0.029 CID_154699623 | CID_154699623 | |
| 0.058 | 0.051 | 0.069 | NMDA receptor agonist | 0.069 0.037 CID_154699623 | CID_154699623 | |
| 0.045 | 0.044 | 0.045 | 5 Hydroxytryptamine 2 agonist | |||
| 0.048 | 0.066 | 0.077 | Phosphodiesterase III inhibitor | 0.077 0.038 CID_154699623 | CID_154699623 | |
| 0.015 | 0.034 | 0.025 | NMDA receptor glycine site antagonist | 0.025 0.016 CID_154699623 | CID_154699623 | |
| 0.05 | 0.073 | 0.062 | HIV-1 reverse transcriptase inhibitor | 0.062 0.057 CID_154699623 | CID_154699623 | |
| 0.068 | 0.102 | 0.113 | Potassium channel activator | 0.113 0.037 CID_154699623 | CID_154699623 | |
| 0.107 | 0.157 | 0.154 | GABA C receptor rho-2 antagonist | 0.154 0.068 CID_154699623 | CID_154699623 | |
| 0.15 | 0.211 | 0.175 | Nitric-oxide synthase stimulant | 0.175 0.14 CID_154699623 | CID_154699623 | |
| 0.105 | 0.18 | 0.121 | Death-associated protein kinase 1 inhibitor | 0.121 0.11 CID_154699623 | CID_154699623 | |
| 0.095 | 0.173 | 0.128 | MAP3K9 inhibitor | 0.128 0.098 CID_154699623 | CID_154699623 | |
| 0.154 | 0.243 | 0.184 | Tyrosine 3 hydroxylase inhibitor | 0.184 0.168 CID_154699623 | CID_154699623 | |
| 0.144 | 0.251 | 0.188 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.188 0.172 CID_154699623 | CID_154699623 | |
| 0.061 | 0.169 | 0.106 | GABA C receptor antagonist | 0.106 0.069 CID_154699623 | CID_154699623 | |
| 0.185 | 0.297 | 0.352 | Apoptosis agonist | 0.352 0.137 CID_154699623 | CID_154699623 | |
| 0.186 | 0.332 | 0.263 | 5 Hydroxytryptamine release inhibitor | 0.263 0.21 CID_154699623 | CID_154699623 | |
| 0.15 | 0.3 | 0.215 | Antibacterial | 0.215 0.212 CID_154699623 | CID_154699623 | |
| 0.103 | 0.266 | 0.165 | Cyclic AMP phosphodiesterase inhibitor | 0.165 0.129 CID_154699623 | CID_154699623 | |
| 0.057 | 0.251 | 0.211 | Neurotrophic factor | 0.211 0.023 CID_154699623 | CID_154699623 | |
| 0.032 | 0.24 | 0.118 | Adenine nucleotide translocase inhibitor | 0.118 0.004 CID_154699623 | CID_154699623 | |
| 0.13 | 0.35 | 0.208 | Calcium channel activator | 0.208 0.202 CID_154699623 | CID_154699623 | |
| 0.035 | 0.356 | 0.249 | DNA polymerase I inhibitor | 0.249 0.017 CID_154699623 | CID_154699623 | |
| 0.055 | 0.436 | 0.147 | CF transmembrane conductance regulator agonist | 0.147 0.081 CID_154699623 | CID_154699623 | |
| 0.021 | 0.553 | 0.22 | Angiogenesis stimulant | 0.22 0.084 CID_154699623 | CID_154699623 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |